Home/Filings/4/0001437749-23-031992
4//SEC Filing

Funtleyder Leslie D. 4

Accession 0001437749-23-031992

CIK 0001742927other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:21 PM ET

Size

5.6 KB

Accession

0001437749-23-031992

Insider Transaction Report

Form 4
Period: 2023-11-13
Transactions
  • Award

    Stock Option (right to buy)

    2023-11-13+8,2008,200 total
    Exercise: $6.04Exp: 2033-11-12Common Stock, par value $0.0001 per share (8,200 underlying)
Footnotes (1)
  • [F1]The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The Option will vest at the rate of one hundred percent (100%) of the shares subject thereto upon the one year anniversary of the date of grant, provided that Awardee remains a director of the Company through such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan.

Issuer

REVIVA PHARMACEUTICALS HOLDINGS, INC.

CIK 0001742927

Entity typeother

Related Parties

1
  • filerCIK 0001775394

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:21 PM ET
Size
5.6 KB